Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 415

1.

Tissue plasminogen activator and plasminogen activator inhibitor-1 gene polymorphisms in patients with chronic periodontitis.

Gürkan A, Emingil G, Saygan BH, Cinarcik S, Atilla G, Köse T, Berdeli A.

J Periodontol. 2007 Jul;78(7):1256-63.

PMID:
17608581
2.

Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in Turkish patients with generalized aggressive periodontitis.

Emingil G, Berdeli A, Gürkan A, Han Saygan B, Köse T, Atilla G.

J Clin Periodontol. 2007 Apr;34(4):278-84. Epub 2007 Jan 25.

PMID:
17257155
3.
4.

4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.

Sartori MT, Wiman B, Vettore S, Dazzi F, Girolami A, Patrassi GM.

Thromb Haemost. 1998 Dec;80(6):956-60.

PMID:
9869167
5.

Association of tissue plasminogen activator and plasminogen activator inhibitor polymorphism with myocardial infarction: a meta-analysis.

Gong LL, Peng JH, Han FF, Zhu J, Fang LH, Wang YH, Du GH, Wang HY, Liu LH.

Thromb Res. 2012 Sep;130(3):e43-51. doi: 10.1016/j.thromres.2012.06.015. Epub 2012 Jul 6.

PMID:
22771216
6.

Plasminogen-activator-inhibitor-1 promoter polymorphism as a risk factor for adult periodontitis in non-smokers.

Izakovicová Hollá L, Bucková D, Fassmann A, Benes P, Znojil V.

Genes Immun. 2002 Aug;3(5):292-4.

8.
9.

4G/5G polymorphism of PAI-1 gene and Alu-repeat I/D polymorphism of TPA gene in Turkish patients with polycystic ovary syndrome.

Karadeniz M, Erdogan M, Berdeli A, Saygili F, Yilmaz C.

J Assist Reprod Genet. 2007 Sep;24(9):412-8. Epub 2007 Jul 28.

10.
11.

Relationship of plasminogen activator inhibitor 1 gene 4G/5G polymorphisms to hypertension in Korean women.

Kim KN, Kim KM, Kim BT, Joo NS, Cho DY, Lee DJ.

Chin Med J (Engl). 2012 Apr;125(7):1249-53.

PMID:
22613596
12.

[Association of plasminogen activator inhibitor-1 gene 4G/5G polymorphism and coronary heart disease in Chinese patients].

Guan L, Ji X, Wang J, Zhang A, Zhang Y, Zhao L.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2002 Oct;19(5):393-6. Chinese.

PMID:
12362314
13.
14.

Plasminogen activator inhibitor -1 gene 4G/5G polymorphism in patients with breast cancer.

Eroglu A, Ulu A, Cam R, Akar N.

J BUON. 2006 Oct-Dec;11(4):481-4.

15.
16.

Role of the tissue-type plasminogen activator -7351C > T and plasminogen activator inhibitor 1 4G/5G gene polymorphisms in central serous chorioretinopathy.

Malle EM, Posch-Pertl L, Renner W, Pinter-Hausberger S, Singer C, Haas A, Wedrich A, Weger M.

Ophthalmic Genet. 2018 Dec;39(6):714-716. doi: 10.1080/13816810.2018.1536219. Epub 2018 Nov 15.

PMID:
30442055
17.

Plasminogen activator inhibitor-1 4G/5G gene polymorphism and primary open-angle glaucoma.

Mossböck G, Weger M, Faschinger C, Schmut O, Renner W.

Mol Vis. 2008 Jul 4;14:1240-4.

18.

Plasminogen activator inhibitor 1 (PAI-1) levels and gene promoter polymorphisms in subjects with colorectal cancer.

Smolarz B, Blasiak J, Kulig A, Romanowicz-Makowska H, Dziki A, Ulanska J, Pander B, Szewczyk T.

J Exp Clin Cancer Res. 2001 Jun;20(2):247-52.

PMID:
11484982
19.

The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.

Stegnar M, Uhrin P, Peternel P, Mavri A, Salobir-Pajnic B, Stare J, Binder BR.

Thromb Haemost. 1998 May;79(5):975-9.

PMID:
9609232
20.

Supplemental Content

Support Center